NCT05732779View on ClinicalTrials.gov

Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Heart Transplant RejectionImmune SuppressionPediatric Heart TransplantMedication NonadherenceHealth BehaviorRemote MonitoringPatient Engagement
Interventions
OTHER

DOT intervention

A mobile health application developed by eMocha Health Inc. facilitates asynchronous mobile video directly observed therapy (DOT) intervention, empowering users to track dose-by-dose medication adherence

Trial Locations (4)

32306

NOT_YET_RECRUITING

FSU College of Medicine, Tallahassee

32610

RECRUITING

University of Florida, Gainesville

33021

RECRUITING

Joe DiMaggio Children's Hospital, Hollywood

33146

RECRUITING

University of Miami, Miller School of Medicine, Coral Gables

All Listed Sponsors
collaborator

emocha Mobile Health, Inc.

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Florida

OTHER